These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 28520087)
1. Geographic variation and risk factors for systemic and limb ischemic events in patients with symptomatic peripheral artery disease: Insights from the REACH Registry. Abtan J; Bhatt DL; Elbez Y; Sorbets E; Eagle K; Reid CM; Baumgartner I; Wu D; Hanson ME; Hannachi H; Singhal PK; Steg PG; Ducrocq G; Clin Cardiol; 2017 Sep; 40(9):710-718. PubMed ID: 28520087 [TBL] [Abstract][Full Text] [Related]
2. Residual Ischemic Risk and Its Determinants in Patients With Previous Myocardial Infarction and Without Prior Stroke or TIA: Insights From the REACH Registry. Abtan J; Bhatt DL; Elbez Y; Sorbets E; Eagle K; Ikeda Y; Wu D; Hanson ME; Hannachi H; Singhal PK; Steg PG; Ducrocq G; Clin Cardiol; 2016 Nov; 39(11):670-677. PubMed ID: 27588731 [TBL] [Abstract][Full Text] [Related]
3. Association between statin therapy and amputation-free survival in patients with critical limb ischemia in the CRITISCH registry. Stavroulakis K; Borowski M; Torsello G; Bisdas T; J Vasc Surg; 2017 Nov; 66(5):1534-1542. PubMed ID: 28807382 [TBL] [Abstract][Full Text] [Related]
4. Acute Limb Ischemia and Outcomes With Vorapaxar in Patients With Peripheral Artery Disease: Results From the Trial to Assess the Effects of Vorapaxar in Preventing Heart Attack and Stroke in Patients With Atherosclerosis-Thrombolysis in Myocardial Infarction 50 (TRA2°P-TIMI 50). Bonaca MP; Gutierrez JA; Creager MA; Scirica BM; Olin J; Murphy SA; Braunwald E; Morrow DA Circulation; 2016 Mar; 133(10):997-1005. PubMed ID: 26826179 [TBL] [Abstract][Full Text] [Related]
5. Fate of individuals with ischemic amputations in the REACH Registry: three-year cardiovascular and limb-related outcomes. Abola MT; Bhatt DL; Duval S; Cacoub PP; Baumgartner I; Keo H; Creager MA; Brennan DM; Steg PG; Hirsch AT; Atherosclerosis; 2012 Apr; 221(2):527-35. PubMed ID: 22321872 [TBL] [Abstract][Full Text] [Related]
6. 3-Year Outcomes of the OLIVE Registry, a Prospective Multicenter Study of Patients With Critical Limb Ischemia: A Prospective, Multi-Center, Three-Year Follow-Up Study on Endovascular Treatment for Infra-Inguinal Vessel in Patients With Critical Limb Ischemia. Iida O; Nakamura M; Yamauchi Y; Fukunaga M; Yokoi Y; Yokoi H; Soga Y; Zen K; Suematsu N; Inoue N; Suzuki K; Hirano K; Shintani Y; Miyashita Y; Urasawa K; Kitano I; Tsuchiya T; Kawamoto K; Yamaoka T; Uesugi M; Shinke T; Oba Y; Ohura N; Uematsu M; Takahara M; Hamasaki T; Nanto S; JACC Cardiovasc Interv; 2015 Sep; 8(11):1493-1502. PubMed ID: 26404203 [TBL] [Abstract][Full Text] [Related]
7. Serum Cholinesterase Levels Are Associated With 2-Year Ischemic Outcomes After Angioplasty and Stenting for Peripheral Artery Disease. Gremmel T; Wadowski PP; Mueller M; Kopp CW; Koppensteiner R; Panzer S J Endovasc Ther; 2016 Oct; 23(5):738-43. PubMed ID: 27328913 [TBL] [Abstract][Full Text] [Related]
8. Cardiovascular outcomes in patients with peripheral arterial disease as an initial or subsequent manifestation of atherosclerotic disease: Results from a Swedish nationwide study. Sigvant B; Hasvold P; Kragsterman B; Falkenberg M; Johansson S; Thuresson M; Nordanstig J J Vasc Surg; 2017 Aug; 66(2):507-514.e1. PubMed ID: 28433332 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of Risk Factors for Limb-Specific Peripheral Vascular Events in Patients With Peripheral Artery Disease: A Post Hoc Analysis of the SEASON Prospective Observational Study. Miyata T; Higashi Y; Shigematsu H; Origasa H; Fujita M; Matsuo H; Naritomi H; Matsuda H; Nakajima M; Yuki S; Awano H Angiology; 2019 Jul; 70(6):506-514. PubMed ID: 30477334 [TBL] [Abstract][Full Text] [Related]
10. Statin therapy after infrainguinal bypass surgery for critical limb ischemia is associated with improved 5-year survival. Suckow BD; Kraiss LW; Schanzer A; Stone DH; Kalish J; DeMartino RR; Cronenwett JL; Goodney PP; J Vasc Surg; 2015 Jan; 61(1):126-33. PubMed ID: 25037607 [TBL] [Abstract][Full Text] [Related]
11. Cohort Study Examining the Association of Immunosuppressant Drug Prescription With Major Adverse Cardiovascular and Limb Events in Patients With Peripheral Artery Disease. Golledge J; Velu R; Quigley F; Jenkins J; Singh TP Ann Vasc Surg; 2022 Jan; 78():310-320. PubMed ID: 34537348 [TBL] [Abstract][Full Text] [Related]
12. Predictive factors for better bypass patency and limb salvage after prosthetic above-knee bypass reconstruction. Klingelhoefer E; Bergert H; Kersting S; Ludwig S; Weiss N; Schönleben F; Grützmann R; Gäbel G J Vasc Surg; 2016 Aug; 64(2):380-388.e1. PubMed ID: 27763266 [TBL] [Abstract][Full Text] [Related]
13. Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization. Sigvant B; Kragsterman B; Falkenberg M; Hasvold P; Johansson S; Thuresson M; Nordanstig J J Vasc Surg; 2016 Oct; 64(4):1009-1017.e3. PubMed ID: 27209402 [TBL] [Abstract][Full Text] [Related]
15. Myocardial injury after endovascular revascularization in critical limb ischemia predicts 1-year mortality: a prospective observational cohort study. Szczeklik W; Krzanowski M; Maga P; Partyka Ł; Kościelniak J; Kaczmarczyk P; Maga M; Pieczka P; Suska A; Wachsmann A; Górka J; Biccard B; Devereaux PJ Clin Res Cardiol; 2018 Apr; 107(4):319-328. PubMed ID: 29177795 [TBL] [Abstract][Full Text] [Related]
16. Major Limb Outcomes Following Lower Extremity Endovascular Revascularization in Patients With and Without Diabetes Mellitus. Shammas AN; Jeon-Slaughter H; Tsai S; Khalili H; Ali M; Xu H; Rodriguez G; Cawich I; Armstrong EJ; Brilakis ES; Banerjee S J Endovasc Ther; 2017 Jun; 24(3):376-382. PubMed ID: 28440113 [TBL] [Abstract][Full Text] [Related]
17. Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease. Bonaca MP; Bhatt DL; Storey RF; Steg PG; Cohen M; Kuder J; Goodrich E; Nicolau JC; Parkhomenko A; López-Sendón J; Dellborg M; Dalby A; Špinar J; Aylward P; Corbalán R; Abola MTB; Jensen EC; Held P; Braunwald E; Sabatine MS J Am Coll Cardiol; 2016 Jun; 67(23):2719-2728. PubMed ID: 27046162 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of a Guideline-Recommended Risk-Reduction Program to Improve Cardiovascular and Limb Outcomes in Patients With Peripheral Arterial Disease. Hussain MA; Al-Omran M; Mamdani M; Eisenberg N; Premji A; Saldanha L; Wang X; Verma S; Lindsay TF JAMA Surg; 2016 Aug; 151(8):742-50. PubMed ID: 27050566 [TBL] [Abstract][Full Text] [Related]
19. Polyvascular disease and long-term cardiovascular outcomes in older patients with non-ST-segment-elevation myocardial infarction. Subherwal S; Bhatt DL; Li S; Wang TY; Thomas L; Alexander KP; Patel MR; Ohman EM; Gibler WB; Peterson ED; Roe MT Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):541-9. PubMed ID: 22715460 [TBL] [Abstract][Full Text] [Related]
20. Epidemiology of lower extremity peripheral artery disease in veterans. Willey J; Mentias A; Vaughan-Sarrazin M; McCoy K; Rosenthal G; Girotra S J Vasc Surg; 2018 Aug; 68(2):527-535.e5. PubMed ID: 29588132 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]